Genic Statistics

Total Valuation

Genic has a market cap or net worth of KRW 166.27 billion. The enterprise value is 170.77 billion.

Market Cap	166.27B
Enterprise Value	170.77B

Important Dates

The next estimated earnings date is Friday, March 21, 2025.

Earnings Date	Mar 21, 2025
Ex-Dividend Date	n/a

Share Statistics

Genic has 7.82 million shares outstanding. The number of shares has increased by 2.58% in one year.

Current Share Class	n/a
Shares Outstanding	7.82M
Shares Change (YoY)	+2.58%
Shares Change (QoQ)	+3.34%
Owned by Insiders (%)	0.04%
Owned by Institutions (%)	n/a
Float	4.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.07
PB Ratio	10.01
P/TBV Ratio	10.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 92.44, with an EV/FCF ratio of -77.51.

EV / Earnings	-1,183.43
EV / Sales	4.66
EV / EBITDA	92.44
EV / EBIT	n/a
EV / FCF	-77.51

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.31.

Current Ratio	1.20
Quick Ratio	0.66
Debt / Equity	0.31
Debt / EBITDA	2.76
Debt / FCF	-2.31
Interest Coverage	0.77

Financial Efficiency

Return on equity (ROE) is -0.95% and return on invested capital (ROIC) is 0.94%.

Return on Equity (ROE)	-0.95%
Return on Assets (ROA)	0.70%
Return on Capital (ROIC)	0.94%
Revenue Per Employee	105.07M
Profits Per Employee	-413,479
Employee Count	349
Asset Turnover	1.27
Inventory Turnover	4.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +499.17% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+499.17%
50-Day Moving Average	19,423.00
200-Day Moving Average	8,799.30
Relative Strength Index (RSI)	60.93
Average Volume (20 Days)	213,821

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Genic had revenue of KRW 36.67 billion and -144.30 million in losses. Loss per share was -20.56.

Revenue	36.67B
Gross Profit	5.88B
Operating Income	320.21M
Pretax Income	-144.30M
Net Income	-144.30M
EBITDA	1.85B
EBIT	320.21M
Loss Per Share	-20.56

Full Income Statement

Balance Sheet

The company has 593.27 million in cash and 5.09 billion in debt, giving a net cash position of -4.50 billion or -575.04 per share.

Cash & Cash Equivalents	593.27M
Total Debt	5.09B
Net Cash	-4.50B
Net Cash Per Share	-575.04
Equity (Book Value)	16.61B
Book Value Per Share	2,122.49
Working Capital	3.19B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.45 billion and capital expenditures -754.87 million, giving a free cash flow of -2.20 billion.

Operating Cash Flow	-1.45B
Capital Expenditures	-754.87M
Free Cash Flow	-2.20B
FCF Per Share	-281.58

Full Cash Flow Statement

Margins

Gross margin is 16.04%, with operating and profit margins of 0.87% and -0.39%.

Gross Margin	16.04%
Operating Margin	0.87%
Pretax Margin	-0.39%
Profit Margin	-0.39%
EBITDA Margin	5.04%
EBIT Margin	0.87%
FCF Margin	n/a

Dividends & Yields

Genic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.58%
Shareholder Yield	-2.58%
Earnings Yield	-0.10%
FCF Yield	-1.33%

Stock Splits

The last stock split was on December 27, 2017. It was a forward split with a ratio of 1.0103113.

Last Split Date	Dec 27, 2017
Split Type	Forward
Split Ratio	1.0103113

Scores

Genic has an Altman Z-Score of 1.95. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.95
Piotroski F-Score	n/a